CD44 and acute coronary syndrome: A recent clinical study revealed that the expression of HYAL2 and CD44 in peripheral blood mononuclear cells (PBMCs) increased in acute coronary syndrome (ACS), especially in patients with plaque erosion compared with stable CAD and healthy people (8).